METASTATIC COLON ADENOCARCINOMA
Clinical trials for METASTATIC COLON ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC COLON ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC COLON ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Triple-Drug cocktail shows promise for Hard-to-Treat colorectal cancer
Disease control CompletedThis early-phase study tested a combination of three drugs—regorafenib, nivolumab, and ipilimumab—in 39 people with advanced colorectal cancer that had spread and was no longer responding to chemotherapy. The goal was to find the safest dose and see if the combination could slow …
Matched conditions: METASTATIC COLON ADENOCARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 17, 2026 05:48 UTC
-
New cocktail shows promise for Tough-to-Treat colorectal cancer
Disease control CompletedThis study tested a combination of three drugs (TAS-102, irinotecan, and bevacizumab) in 42 people with advanced colorectal cancer that had already been treated and spread or couldn't be removed. The goal was to see if this mix could slow cancer growth better than standard treatm…
Matched conditions: METASTATIC COLON ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated May 14, 2026 12:04 UTC